Servier

Servier, established in 1954, is a prominent independent pharmaceutical company operating under a unique non-profit foundation governance. Headquartered in Suresnes, France, Servier is deeply committed to advancing healthcare through rigorous scientific research and development. The company's core mission revolves around creating, testing, and developing innovative medicinal products to address significant unmet medical needs. With a strong focus on therapeutic progress, Servier dedicates substantial resources to its three research centers, fostering an environment of continuous innovation in drug discovery and development. This dedication ensures a pipeline of novel treatments aimed at improving patient outcomes across various disease areas.

Operating on a global scale, Servier manages its extensive operations across 7 locations worldwide. The company employs a substantial workforce of over 10,000 individuals, contributing to its robust R&D efforts and manufacturing capabilities. These dedicated teams are instrumental in translating scientific breakthroughs into tangible treatments. For insights into the people driving this innovation, one can Meet Servier's team. Servier's production centers are strategically positioned globally to manufacture and package its medicinal products, ensuring widespread availability and adherence to stringent quality standards.

Servier's product portfolio encompasses both commercial-stage and clinical-stage pharmaceutical assets, with a particular emphasis on critical therapeutic areas such as oncology, cardiovascular diseases, and rare diseases. The company generates significant revenue, reported at $5.9 billion, underscoring its market presence and the impact of its pharmaceutical offerings. Servier's commitment extends beyond product development to ensuring patient access to vital medicines.